# Juxtapid

NDC: 76431-120
Generic name: lomitapide mesylate
Labeler / Manufacturer: Amryt Pharmaceuticals DAC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20130103
Marketing ended: 20261025
FDA application: NDA203858

## Active ingredients

- LOMITAPIDE MESYLATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76431-120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76431-120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4c45bb5-15f4-437e-ab98-a649b3676d14